Search Results

Displaying Results 1-1 of 1 "'ARVN'"
Making a selection with these dropdown will cause content on this page to change. News search result will update as each option is selected.
PROTAC Market Shows Accelerated Growth During the Forecast Period (2025-2034) Amid Rising Targeted Therapy Demand | DelveInsight

Feb 10, 2026, 17:31 ET PROTAC Market Shows Accelerated Growth During the Forecast Period (2025-2034) Amid Rising Targeted Therapy Demand | DelveInsight

most patients with early-stage breast cancer do not go on to develop metastatic disease.Leading PROTAC companies, such as Arvinas (NASDAQ: ARVN), Pfizer (NYSE: PFE), Novartis (SWX: NOVN), Astellas Pharma (TYO: 4503), Dialectic Therapeutics, and others, are developing novel PROTAC that can

More news about: DelveInsight Business Research LLP

Making a selection with these dropdown will cause content on this page to change. News search result will update as each option is selected.